SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-052671
Filing Date
2023-10-10
Accepted
2023-10-10 16:53:44
Documents
2
Period of Report
2023-10-09

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 12886
2 EX-24 krtx-ex24.htm EX-24 7676
  Complete submission text file 0000950170-23-052671.txt   21908
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Issuer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KARUNA THERAPEUTICS, INC. 33 ARCH STREET, SUITE 3110 BOSTON MA 02110
Business Address
Brannan Stephen K. (Reporting) CIK: 0001777631 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38958 | Film No.: 231318514